Wendell W. Weber

5.1k citations

120 papers · 4.0k indexed · 1 hit paper · h-index 33

Co-authors: David W. Hein Kostas P. Vatsis Gerald N. Levy Irene B. Glowinski K J Martell Sanford N. Cohen D. J. Hearse Herbert Andres
Topics: Polyamine Metabolism and Applications (18 papers)Carcinogens and Genotoxicity Assessment (17 papers)Chemical Reactions and Isotopes (14 papers)
Cited by: Pharmacology Cancer Research Biochemistry
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States China France

In The Last Decade

Wendell W. Weber

119 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

N-acetylation pharmacogenetics.

1985 533 citations Wendell W. Weber, David W. Hein Pharmacological Reviews profile →

Peers

Countries citing papers authored by Wendell W. Weber

Since Specialization

Citations

This map shows the geographic impact of Wendell W. Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendell W. Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendell W. Weber more than expected).

Fields of papers citing papers by Wendell W. Weber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendell W. Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendell W. Weber. The network helps show where Wendell W. Weber may publish in the future.

Co-authorship network of co-authors of Wendell W. Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Wendell W. Weber. A scholar is included among the top collaborators of Wendell W. Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendell W. Weber. Wendell W. Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PrefaceWerner Kalow Commemorative IssueAspet/aacc ConferenceNew Directions in Pharmacogenetics and EcogeneticsGenetic Defenses Against Environmental ImpactsResponses to Infections, Foods, and Environmental Toxicants 2001 ·Drug Metabolism and Disposition ·Wendell W. Weber,Robert L. Smith	1
2	Pharmacogenetic Tactics and Strategies 2001 ·Pediatric Drugs ·Wendell W. Weber	3
3	The legacy of pharmacogenetics and potential applications 2001 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Wendell W. Weber	18
4	Effect of pharmacogenetics on medicine 2001 ·Environmental and Molecular Mutagenesis ·Wendell W. Weber	11
5	Characterization of Naturally Occurring and Recombinant HumanN-Acetyltransferase Variants Encoded byNAT1* 2000 ·Molecular Pharmacology ·(unknown),Kostas P. Vatsis,Wendell W. Weber	46
6	Influence of heredity on human sensitivity to environmental chemicals 1995 ·Environmental and Molecular Mutagenesis ·Wendell W. Weber	22
7	Nomenclature for N-acetyltransferases 1995 ·Pharmacogenetics ·Kostas P. Vatsis,Wendell W. Weber,Douglas A. Bell,Jean‐Marie Dupret,David A. Evans,Denis M. Grant,David W. Hein,Henry J. Lin,Urs Meyer,(unknown),Edith Sim,T. Suzuki,Yasushi Yamazoe	318
8	2-Aminofluorene metabolism and DNA adduct formation by mononuclear leukocytes from rapid and slow acetylator mouse strains 1994 ·Carcinogenesis ·Gerald N. Levy,(unknown),Wendell W. Weber	26
9	Polymorphic N-acetylation of 2-aminofluorene by cell-free colon extracts from inbred mice 1993 ·Pharmacogenetics ·Gerald N. Levy,K J Martell,Wendell W. Weber	3
10	Individual variability in p-aminobenzoic acid N-acetylation by human N-acetyltransferase (NAT1) of peripheral blood 1993 ·Pharmacogenetics ·Wendell W. Weber,Kostas P. Vatsis	54
11	DNA adduct levels in congenic rapid and slow acetylator mouse strains following chronic administration of 4-aminobiphenyl 1992 ·Carcinogenesis ·Thomas J. Flammang,Letha H. Couch,Gerald N. Levy,Wendell W. Weber,Carolyn Wise	18
12	N-acetylation of aromatic amines: genetic polymorphism in inbred rat strains 1991 ·Pharmacogenetics ·Daland R. Juberg,(unknown),Wendell W. Weber	15
13	Human N-acetylation genotype determination with urinary caffeine metabolites 1990 ·Clinical Pharmacology & Therapeutics ·(unknown),Lawrence K. Silbart,(unknown),Inese Z. Beitins,Wendell W. Weber	34
14	2-Aminofluorene-DNA adduct formation in acetylator congenic mouse lines 1989 ·Carcinogenesis ·Gerald N. Levy,Wendell W. Weber	32
15	Michaelis menten constants for arylamine drugs in rapid and slow human acetylator liver 1988 ·The FASEB Journal ·(unknown),(unknown),Wendell W. Weber	2
16	N-acetylation pharmacogenetics.breakdown → 1985 ·Pharmacological Reviews ·Wendell W. Weber,David W. Hein	533
17	Polymorphic N-acetylation of phenelzine and monoacetylhydrazine by highly purified rabbit liver isoniazid N-acetyltransferase. 1982 ·Drug Metabolism and Disposition ·David W. Hein,Wendell W. Weber	5
18	Biochemical evidence for the coexistence of monomorphic and polymorphic N-acetyltransferase activities on a common protein in rabbit liver. 1982 ·Journal of Pharmacology and Experimental Therapeutics ·David W. Hein,Mariko Hirata,Irene B. Glowinski,Wendell W. Weber	33
19	[35] N-acetyltransferase and arylhydroxamic acid acyltransferase 1981 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Wendell W. Weber,Charles M. King	25
20	Rodent models of the human isoniazid-acetylator polymorphism. 1979 ·Drug Metabolism and Disposition ·(unknown),Wendell W. Weber	17

About Wendell W. Weber

Wendell W. Weber is a scholar working on Pharmaceutical Science, Cancer Research and Pharmacology, having authored 120 papers that have together received 4.0k indexed citations. Recurring topics across this work include Polyamine Metabolism and Applications (18 papers), Carcinogens and Genotoxicity Assessment (17 papers) and Chemical Reactions and Isotopes (14 papers). The work is most often cited by research in Pharmacology (683 citations), Cancer Research (1.1k citations) and Biochemistry (459 citations). Wendell W. Weber has collaborated with scholars based in United States, China and France. Frequent co-authors include David W. Hein, Kostas P. Vatsis, Gerald N. Levy, Irene B. Glowinski, K J Martell, Sanford N. Cohen, D. J. Hearse, Herbert Andres, Denis M. Grant and Jing‐Gung Chung. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact